138 related articles for article (PubMed ID: 23126425)
1. Insulin-like growth factor-binding protein-6 and cancer.
Bach LA; Fu P; Yang Z
Clin Sci (Lond); 2013 Feb; 124(4):215-29. PubMed ID: 23126425
[TBL] [Abstract][Full Text] [Related]
2. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
Fu P; Liang GJ; Khot SS; Phan R; Bach LA
J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-6 five years on; not so 'forgotten'?
Bach LA
Growth Horm IGF Res; 2005 Jun; 15(3):185-92. PubMed ID: 15914054
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
7. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes.
Hastie PM; Onagbesan OM; Haresign W
Anim Reprod Sci; 2004 Aug; 84(1-2):93-105. PubMed ID: 15302390
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth.
Grellier P; De Galle B; Babajko S
Cancer Res; 1998 Apr; 58(8):1670-6. PubMed ID: 9563481
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
13. IGFBPs are involved in xenograft development in nude mice.
Babajko S; Grellier P; de Gallé B; Menouny M; Binoux M
Med Pediatr Oncol; 2001 Jan; 36(1):154-6. PubMed ID: 11464872
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
15. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
16. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.
Remacle-Bonnet M; Garrouste F; el Atiq F; Marvaldi J; Pommier G
J Clin Invest; 1995 Jul; 96(1):192-200. PubMed ID: 7542277
[TBL] [Abstract][Full Text] [Related]
17. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-6: the "forgotten" binding protein?
Bach LA
Horm Metab Res; 1999; 31(2-3):226-34. PubMed ID: 10226806
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
